COVID-19 Vaccine To Vaccination: Why Leaders Must Invest In Delivery Strategies Now: Analysis describe lessons learned from past pandemics and vaccine campaigns about the path to successful vaccine delivery for COVID-19.
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Worldwide, leaders are implementing nonpharmaceutical interventions to slow transmission of the novel coronavirus while pursuing vaccines that confer immunity to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. In this article we describe lessons learned from past pandemics and vaccine campaigns about the path to successful vaccine delivery. The historical record suggests that to have a widely immunized population, leaders must invest in evidence-based vaccine delivery strategies that generate demand, allocate and distribute vaccines, and verify coverage. To generate demand, there must be an understanding of the roots of vaccine hesitancy, involvement of trusted sources of authority in advocacy for vaccination, and commitment to longitudinal engagement with communities. To allocate vaccines, qualified organizations and expert coalitions must be allowed to determine evidence-based vaccination approaches and generate the political will to ensure the cooperation of local and national governments. To distribute vaccines, the people and organizations with expertise in manufacturing, supply chains, and last-mile distribution must be positioned to direct efforts. To verify vaccine coverage, vaccination tracking systems that are portable, interoperable, and secure must be identified. Lessons of past pandemics suggest that nations should invest in evidence-informed strategies to ensure that coronavirus disease 2019 (COVID-19) vaccines protect individuals, suppress transmission, and minimize disruption to health services and livelihoods.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Figueiredo, A., Simas, C., Karafillakis, E., Paterson, P., & Larson, H. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31558-0 · Cited by 1,143
Strategies for addressing vaccine hesitancy–A systematic review
Jarrett, C., Wilson, R., O’Leary, M., Eckersberger, E., & Larson, H. J. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.04.040 · Cited by 1,066
Redefining global health-care delivery
Kim, J. Y., Farmer, P., & Porter, M. E. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61047-8 · Cited by 323
Health Communication and Vaccine Hesitancy
Goldstein, S., MacDonald, N. E., & Guirguis, S. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.04.042 · Cited by 265
Cited by
COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates
Sallam, M. (2021) · Vaccines · doi:10.3390/vaccines9020160 · Cited by 2,128
Israel’s rapid rollout of vaccinations for COVID-19
Rosen, B., Waitzberg, R., & Israeli, A. (2021) · Israel Journal of Health Policy Research · doi:10.1186/s13584-021-00440-6 · Cited by 271
A Global Study on the Correlates of Gross Domestic Product (GDP) and COVID-19 Vaccine Distribution
(2022) · doi:10.3390/vaccines10020266 · Cited by 75
Just Keep Rolling?—An Encompassing Review towards Accelerated Vaccine Product Life Cycles
(2023) · doi:10.3390/vaccines11081287 · Cited by 11
Metadata
- Authors
- Weintraub, R. L., Subramanian, L., Karlage, A., Ahmad, I., & Rosenberg, J.
- Venue
- Health Affairs
- Publisher
- Health Affairs Publishing, LLC
- Published
- 2021-01-01
- Volume
- 40
- Issue
- 1
- Pages
- 33-41
- ISSN
- 0278-2715 (ISSN-L)
- 1544-5208
- OpenAlex
- W3102131517
- Cited by
- 104
- References
- 4
- FWCI
- 11.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.